1. When to diagnose and how to treat prostate cancer in the ‘not too fit’ elderly 
Philipp Dahm, Ari D. Silverstein, Alon Z. Weizer, Alfonso Crisci, Johannes Vieweg, David F. Paulson 
Critical Reviews in Oncology / Hematology 
Volume 48, Issue 2, Pages (November 2003)
DOI: /j.critrevonc

2. Fig. 1
Time to cancer-associated death and time to death of any cause in patients of age 70 years or older (n=461) undergoing radical perineal prostatectomy.
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )

3. Fig. 2
Proportion of pathologic tumor stages (organ confined (OC); specimen confined (SC); margin positive (MP)) in patients of age 70 years or older undergoing radical perineal prostatectomy grouped by the year of surgery.
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )

4. Fig. 3
Distribution of Gleason score categories [2–10] in patients of age 70 years or older undergoing radical perineal prostatectomy grouped by the year of surgery.
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )

5. Fig. 4
Time to cancer-associated death in patients of age 70 years or older undergoing radical perineal prostatectomy grouped by Gleason score categories [2–10].
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )

6. Fig. 5
Time to cancer-associated death in patients of age 70 years or older and margin positive disease grouped by Gleason score categories [2–10].
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )

7. Fig. 6
Time to cancer-associated death with 95% confidence intervals in patients of age 70 years or older undergoing radical perineal prostatectomy grouped by Gleason scores [4–10].
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )